IMC 14.1% 10.5¢ immuron limited

News: IMC Immuron Says US DOD Naval Medical Research Center Requests Meeting With FDA On Two Phase...

  1. 191,623 Posts.
    lightbulb Created with Sketch. 2809

    June 9 (Reuters) - Immuron Ltd (IMC) :

    • US DOD NAVAL MEDICAL RESEARCH CENTER REQUESTS MEETING WITH FDA FOR GUIDANCE ON TWO PHASE 2 TRIALS TO PREVENT ACUTE INFECTIOUS DIARRHEA
    • IMMURON LTD - TWO HUMAN PHASE II CLINICAL TRIALS TO BE CONDUCTED IN 2021
    • IMMURON - ONE TRIAL TO FOCUS ON ABILITY OF HYPERIMMUNE PRODUCT TO PROTECT VOLUNTEERS AGAINST MODERATE TO SEVERE CAMPYLOBACTERIOSIS
    • IMMURON - SECOND TRIAL WILL FOCUS ON ETEC INFECTIONS
    • IMMURON LTD - NMRC PLANS TO FILE IND APPLICATION LATER THIS YEAR, COMMENCE PHASE 2 CLINICAL STUDIES DURING H1 2021
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.013(14.1%)
Mkt cap ! $23.93M
Open High Low Value Volume
9.9¢ 10.5¢ 9.8¢ $41.97K 418.5K

Buyers (Bids)

No. Vol. Price($)
2 43600 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 149018 6
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.